Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For DTM
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 13.48 0.71 0.63
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -5.23 17.61 18.58
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.62 42.95 42.68
Cash -26.81 0.42 0.58
Capex 34.69 -1.01 -1.55
Free Cash Flow 205.27 1.76 0.58
Revenue -1.67 2.47 2.52
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 9.74 0.57 0.52
Operating Margin 5.06 0.52 0.49
ROA -19.56 0.01 0.01
ROE -20.35 0.02 0.03
ROIC -18.98 0.01 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of DTM is permitted for members.
5 Growth
The "Growth Entry" for the Focus of DTM is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of DTM is permitted for members.